Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

25 March 2019

Today, the Board of Convatec Group Plc (“Convatec” or “the Group”) announced the appointment of Karim Bitar as Chief Executive Officer, effective from 30 September 2019. Following this appointment, Sir Christopher Gent, the Chairman, has advised the Board that he wishes to retire and therefore will not seek re-election as a Director at the Group’s forthcoming Annual General Meeting on 9 May 2019. A Special Nominations Committee has been established to identify Sir Christopher’s successor as Chair of the Board. 

Rick Anderson, currently interim Chief Executive Officer (“CEO”) of Convatec, has agreed to temporarily serve as Executive Chairman until a new Chair has been appointed, effective from 9 May 2019. The Board has appointed Rick to the Executive Chairman role on a temporary basis to maintain continuity within the senior leadership of the Company during the transitional period until the new Chief Executive Officer joins on 30 September and to drive the recently announced transformation initiative. Rick will then move to be Non-Executive Chairman until a permanent appointment is made.

The Board also announces that Steve Holliday, Deputy Chairman and Senior Independent Director, has resigned as a member of the Board with effect from 31 March 2019. In his place, Margaret Ewing will be appointed as Senior Independent Director from that date and Ros Rivaz will be appointed as Chair of the Remuneration Committee and member of the Audit & Risk Committee. Both Margaret and Ros are currently Independent Non-Executive Directors of Convatec and have strong relevant executive and non-executive experience across the sector and with large listed businesses.

Sir Christopher Gent said:

“Following the announcement of Karim Bitar’s appointment as Chief Executive Officer, both Steve and I have concluded that this is the right time to step down from the Board of Convatec. I would like to thank Steve for his valuable contribution to the Board since he became a Director in 2016, in particular successfully leading the process to appoint our new CEO.

“I would also like to thank Rick for agreeing to stand in as Executive Chairman until our new CEO, Karim Bitar, commences his duties at the end of September, or until such time as the Board is in a position to announce the appointment of a new Chair.

“Under Rick’s leadership, Convatec is now making good progress on our Pivot to Growth initiative, designed to address the past performance issues within and across the Group and to establish the platform to return the Group to the growth rate rightly expected by our shareholders.

“Margaret and Ros have made a significant contribution to Convatec since joining the Board in 2017. Their additional responsibilities will serve shareholders well as Convatec continues to execute on its operational transformation agenda.”

This announcement is made in accordance with Listing Rule 9.6.11R(1).

 

Enquiries

 
Analysts and Investors 
                                                                                                                     

investorrelations@convatec.com

John Crosse, VP Investor Relations

+44 (0)7500 141435

Mark Reynolds, Director Investor Relations

+44 (0)7551 036625



Media


mediarelations@convatec.com

Bobby Leach, VP Group Corporate Affairs                      

+44 (0)7770 842226

James Bradley / Alastair Elwen, Finsbury

+44 (0)207 2513801

 

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.

Press Release

See all

5/13/2022

5/13/2022

Convatec Group Plc Annual Results 2018

Convatec Group Plc Annual Results 2018

Read more

5/13/2022

5/13/2022

2018 Annual Report & Accounts

2018 Annual Report & Accounts

Read more

5/13/2022

5/13/2022

Appointment of Chief Executive Officer

Appointment of Chief Executive Officer

Read more

5/13/2022

5/13/2022

Board Changes

Board Changes

Read more

5/13/2022

5/13/2022

Results of Annual General Meeting

Results of Annual General Meeting

Read more

5/13/2022

5/13/2022

Convatec partners with EWMA to support Research Grants in 2019

Convatec partners with EWMA to support Research Grants in 2019

Read more

5/13/2022

5/13/2022

Board Change

Board Change

Read more

5/13/2022

5/13/2022

Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancreas System

Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancreas System

Read more

5/13/2022

5/13/2022

Convatec Group Plc First Half Results 2019

Convatec Group Plc First Half Results 2019

Read more

5/13/2022

5/13/2022

John McAdam appointed Chairman of Convatec

John McAdam appointed Chairman of Convatec

Read more

5/13/2022

5/13/2022

Acquisition of Southlake Medical Supplies

Acquisition of Southlake Medical Supplies

Read more

5/13/2022

5/13/2022

Trading Update for the three months ended 30 September 2019

Trading Update for the three months ended 30 September 2019

Read more